169 related articles for article (PubMed ID: 29900911)
1. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma.
Marimuthu M; Andiappan M; Wahab A; Muthusekhar MR; Balakrishnan A; Shanmugam S
Indian J Dent Res; 2018; 29(3):291-297. PubMed ID: 29900911
[TBL] [Abstract][Full Text] [Related]
2. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.
Saito T; Mitomi H; Imamhasan A; Hayashi T; Mitani K; Takahashi M; Kajiyama Y; Yao T
Virchows Arch; 2014 Feb; 464(2):135-43. PubMed ID: 24464051
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
6. Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.
Jamal B; Sengupta PK; Gao ZN; Nita-Lazar M; Amin B; Jalisi S; Bouchie MP; Kukuruzinska MA
Oral Oncol; 2012 Jun; 48(6):523-9. PubMed ID: 22341307
[TBL] [Abstract][Full Text] [Related]
7. A possible role for the WNT-1 pathway in oral carcinogenesis.
Lo Muzio L
Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525
[TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
9. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
11. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt/β-catenin pathway.
Ma Y; Hu X; Shang C; Zhong M; Guo Y
Tumour Biol; 2017 Jul; 39(7):1010428317717670. PubMed ID: 28671055
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
13. KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.
Cui Z; Cui Y; Yang S; Luo G; Wang Y; Lou Y; Sun X
Cell Biol Int; 2017 Apr; 41(4):392-404. PubMed ID: 28150891
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
16. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
17. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway.
Ai Y; Wu S; Zou C; Wei H
J Cell Mol Med; 2020 Sep; 24(18):10512-10524. PubMed ID: 32691935
[TBL] [Abstract][Full Text] [Related]
18. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
[TBL] [Abstract][Full Text] [Related]
19. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract][Full Text] [Related]
20. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.
Lavergne E; Hendaoui I; Coulouarn C; Ribault C; Leseur J; Eliat PA; Mebarki S; Corlu A; Clément B; Musso O
Oncogene; 2011 Jan; 30(4):423-33. PubMed ID: 20856206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
